Webinars

14-3-3 eta Protein: A New Direction in the Early Diagnosis of Rheumatoid Arthritis

Chapters

Date: Monday, May 06, 2013

Author: Maksymowych, Walter, MD
Scientist, Alberta Heritage Foundation for Medical Research
Consultant Rheumatologist and Professor of Medicine
University of Alberta
Edmonton, Alberta
  
Also by this Author ▸

Category: CE Credit, Webinar

Description: Dr. Walter Maksymowych discusses the diagnostic and prognostic value of the 14-3-3 eta protein in rheumatoid arthritis and the clinical relevance of a new assay that measures this biomarker.

Learning objectives — at the conclusion of this program participants will be able to:
• Describe the pathophysiology of a new inflammatory
mediator, 14-3-3 eta, in rheumatoid arthritis (RA)
• Demonstrate how 14-3-3 enhances early diagnosis for
patients with RA
• Discuss the prognostic utility of 14-3-3 in rheumatoid and
psoriatic arthritis

Evaluation and P.A.C.E. credit

Related Content

Presentation:
The Appropriate Use of Diagnostic Testing in the Management of Rheumatoid Arthritis
Bergman, Martin J., MD

Presentation:
Is It Truly an Allergy? Making the Differential Diagnosis
Randhawa, Inderpal, MD

Expert Insight:
14-3-3eta (η) Protein — A New Biomarker for Rheumatoid Arthritis
Maksymowych, Walter, MD